Pharmaceutical Company Agrees to Pay $4.7 Million to Settle False Claims Act & Kickback Allegations
By George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law On July 17, 2026, the U.S. Department of Justice (DOJ) announced that EyePoint Pharmaceuticals, Inc. (EyePoint), agreed to pay $4,657,463.18 (close to $4.7 million) to resolve allegations involving its injectable eye medication, DEXYCU. The Massachusetts-based drug company agreed […]
Forest Labs Agree to Pay $38 Million Settlement to End Whistle Blower’s FCA Suit
By George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law On December 15, 2016, Forest Laboratories agreed to pay $38 million to resolve a whistle blower’s False Claims Act (FCA) suit involving allegations that it paid kickbacks to doctors who prescribed three of the company’s drugs, the U.S. […]